ScholarlyCommons
metadata only
CC BY 4.0
Degree of Cyclooxygenase-2 Inhibition Modulates Blood Pressure Response
BACKGROUND: – Large clinical trials compared distinct nonsteroidal anti-inflammatory drugs in terms of their risk of adverse cardiovascular events. However, whether pharmacologically equipotent doses were used, that is, whether a similar degree of COX (cyclooxygenase)-2 inhibition was achieved, was
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Degree of Cyclooxygenase-2 Inhibition Modulates Blood Pressure Response#1416915
- Degree of Cyclooxygenase-2 Inhibition Modulates Blood Pressure Response#1136664
- Efficacy and Safety Study of Lipid-Lowering Effects of XueZhiKang (XZK) in Patients With Hyperlipidemia#802135
- Anti Inflammatory Treatment of Hypertension#143686
- Study of TNF-Antagonism in Metabolic Syndrome#879207
Record · ID 1416814
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive